skyglide Explore Beyond
People with obesity or who are overweight and hoping to lose weight with the assistance of medication have a new option. On Nov. 8, the U.S. Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound, which, according to clinical trials, helped participants lose up to 52 pounds in 16 months. “This is the most effective form of pharmaceutical obesity …
Read More »As FDA Approves Zepbound, Woman Shares Mounjaro Weight Loss
